Coya Therapeutics, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Coya Therapeutics, Inc. (COYA) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-08-11
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2026-06-30 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2026-03-31 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2025-12-31 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2025-09-30 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
- Coya Therapeutics, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-11 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-16 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-19 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |